Gliclazide Modified Release: A Viewpoint by Andrew Harrower

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.9, 2002-01, pp. : 1365-1366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gliclazide Modified Release

By Adis International Limited

Drugs, Vol. 65, Iss. 10, 2005-01 ,pp. : 1449-1450

Adis International

Access to resources Recommend Favorite

Gliclazide Modified Release

By McGavin J.K. Perry C.M. Goa K.L.

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1357-1364

Adis International

Access to resources Recommend Favorite

Development of Extended Zero-Order Release Gliclazide Tablets by Central Composite Design

By Vijayalakshmi P. Devi V. Kusum Narendra C. Srinagesh S.

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 1, 2008-01 ,pp. : 33-45

Informa Healthcare

Access to resources Recommend Favorite

Galantamine Extended Release: A Viewpoint by Martin R. Farlow

By Farlow Martin R.

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 682-683

Adis International

Access to resources Recommend Favorite

Prolonged-Release Ciprofloxacin: A Viewpoint by Jean L. Fourcroy

By Fourcroy J.L.

American Journal of Drug Delivery, Vol. 4, Iss. 2, 2006-01 ,pp. : 121-121

Adis International

Access to resources Recommend Favorite